panobinostat (MTX110) / Biodexa Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
panobinostat (MTX110) / Biodexa Pharma
NCT04269343: Infusion of Panobinostat (MTX110) Into the Fourth Ventricle or Tumor Resection Cavity in Children and Adults With Recurrent Medulloblastoma

Not yet recruiting
1
5
US
Treatment with MTX110
The University of Texas Health Science Center, Houston
Medulloblastoma
12/22
12/22
NCT04264143: CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

Completed
1
9
US
Infusate with MTX110 and gadolinium, Convection-Enhanced Delivery (CED)
Luca Szalontay, Midatech Pharma US Inc.
Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma
04/22
11/23
NCT04315064: Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults With Recurrent Medulloblastoma

Recruiting
1
5
US
Treatment with MTX110
The University of Texas Health Science Center, Houston, Midatech Pharma plc
Medulloblastoma
12/25
12/25
MAGIC-G1, NCT05324501: A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma

Active, not recruiting
1
36
US
MTX110, Programmable pump and catheter system
Biodexa Pharmaceuticals
Recurrent Glioblastoma
08/28
08/28

Download Options